| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1537-2995.2001.41080977.X |
| P698 | PubMed publication ID | 11493727 |
| P2093 | author name string | Crowley JP | |
| Valeri CR | |||
| Lieberthal W | |||
| Khuri SF | |||
| Loscalzo J | |||
| Pivacek LE | |||
| Ragno G | |||
| Cassidy G | |||
| P2860 | cites work | Experimental basis for the use of red cell transfusion in the management of anemic-thrombocytopenic patients. | Q33451678 |
| The bleeding time as a screening test for evaluation of platelet function | Q33464411 | ||
| The contribution of the haematocrit to thrombocytopenic bleeding in experimental animals | Q33492799 | ||
| The volume of blood shed during the bleeding time correlates with the peripheral venous hematocrit | Q33500692 | ||
| Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment | Q34237060 | ||
| A critical reappraisal of the bleeding time | Q38143842 | ||
| The red cell transfusion trigger: has a sin of commission now become a sin of omission? | Q47855558 | ||
| Effects of temperature on bleeding time and clotting time in normal male and female volunteers | Q50113578 | ||
| The hemostatic effect of packed red cell transfusion in patients with anemia. | Q50854748 | ||
| Modified ultrafiltration attenuates dilutional coagulopathy in pediatric open heart operations. | Q53960861 | ||
| Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass. | Q54002264 | ||
| THE RELATION OF BLOOD PLATELETS TO HEMORRHAGIC DISEASE | Q54107270 | ||
| P433 | issue | 8 | |
| P304 | page(s) | 977-983 | |
| P577 | publication date | 2001-08-01 | |
| P1433 | published in | Transfusion | Q15758500 |
| P1476 | title | Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss | |
| P478 | volume | 41 |
| Q36068943 | 2015 proceedings of the National Heart, Lung, and Blood Institute's State of the Science in Transfusion Medicine symposium. |
| Q33376798 | A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation |
| Q64122196 | ACVIM consensus statement on the diagnosis and treatment of chronic hepatitis in dogs |
| Q36658472 | An approach to transfusion and hemorrhage in trauma: current perspectives on restrictive transfusion strategies. |
| Q89090980 | Association of Perioperative Red Blood Cell Transfusions With Venous Thromboembolism in a North American Registry |
| Q41573535 | Changes in platelet function following cold storage of RBC suspensions |
| Q28194204 | Circulation and hemostatic function of autologous fresh, liquid-preserved, and cryopreserved baboon platelets transfused to correct an aspirin-induced thrombocytopathy |
| Q38725772 | Commentary on 50 years of research at the NBRL, Boston, Massachusetts |
| Q40166447 | Comparison of haemostatic function of PAS-C-platelets vs. plasma-platelets in reconstituted whole blood using impedance aggregometry and thromboelastography |
| Q51122364 | Comparison of the accuracy of hemoglobin point of care testing using HemoCue and GEM Premier 3000 with automated hematology analyzer in emergency room. |
| Q33433620 | Cryopreserved platelet concentrate transfusions in 43 dogs: a retrospective study (2007-2013). |
| Q35856151 | Current status of transfusion triggers for red blood cell concentrates |
| Q36835603 | Diagnostic performance of the platelet function analyzer (PFA-100) for the detection of disorders of primary haemostasis in patients with a bleeding history-a systematic review and meta-analysis |
| Q50487834 | Effects of hematocrit and red blood cell-independent viscosity on canine thromboelastographic tracings. |
| Q37996341 | Emerging treatment strategies for trauma-induced coagulopathy |
| Q53394850 | Examining platelet adhesion via Stokes flow simulations and microfluidic experiments. |
| Q33944224 | Factor XIII activity mediates red blood cell retention in venous thrombi |
| Q44195467 | Feasibility of a restrictive red-cell transfusion policy for patients treated with intensive chemotherapy for acute myeloid leukaemia |
| Q37516990 | Gender disparities in red blood cell transfusion in elective surgery: a post hoc multicentre cohort study |
| Q28307377 | HIF prolyl hydroxylase inhibitors for anemia |
| Q41441283 | Haemostatic function and biomarkers of endothelial damage before and after RBC transfusion in patients with haematologic disease. |
| Q35846049 | Hematological Changes in Patients Undergoing Coronary Artery Bypass Surgery: a Prospective Study |
| Q50563846 | Hemostatic function of buffy coat platelets in additive solution treated with pathogen reduction technology. |
| Q47669729 | Heterozygosity for P2Y12 receptor gene mutation associated with postoperative hemorrhage in a Greater Swiss Mountain dog. |
| Q37059222 | Impact of experimental haemodilution on platelet function, thrombin generation and clot firmness: effects of different coagulation factor concentrates |
| Q39356470 | Impact of red blood cell transfusion strategies in haemato-oncological patients: a systematic review and meta-analysis. |
| Q35687025 | In vitro measurement of particle margination in the microchannel flow: effect of varying hematocrit |
| Q45070700 | In vitro testing of fresh and lyophilized reconstituted human and baboon platelets |
| Q51788177 | In vitro testing of platelets using the thromboelastogram, platelet function analyzer, and the clot signature analyzer to predict the bleeding time. |
| Q27023734 | Indications for platelet transfusion in patients with thrombocytopenia |
| Q33413225 | Intracranial haemorrhage in thrombocytopenic haematology patients--a nested case-control study: the InCiTe study protocol |
| Q92057146 | In Vitro Measurement and Modeling of Platelet Adhesion on VWF-Coated Surfaces in Channel Flow |
| Q48624072 | Laboratory predictors of bleeding and the effect of platelet and RBC transfusions on bleeding outcomes in the PLADO trial |
| Q38206394 | Management of Acute Myeloid Leukemia in the Intensive Care Setting. |
| Q21092902 | Management of bleeding and coagulopathy following major trauma: an updated European guideline |
| Q36296517 | Management of bleeding following major trauma: a European guideline |
| Q33919178 | Management of bleeding following major trauma: an updated European guideline |
| Q36651166 | Management of coagulopathy in the setting of acute neurosurgical disease and injury |
| Q34802880 | Massive blood transfusion in the elective surgical setting. |
| Q83968093 | Massive transfusion and coagulopathy: pathophysiology and implications for clinical management |
| Q38024467 | Massive transfusion: an overview of the main characteristics and potential risks associated with substances used for correction of a coagulopathy |
| Q33376755 | Nonsurgical bleeding diathesis in anemic thrombocytopenic patients: role of temperature, red blood cells, platelets, and plasma-clotting proteins |
| Q35998221 | Patient Blood Management: A Patient-Orientated Approach to Blood Replacement with the Goal of Reducing Anemia, Blood Loss and the Need for Blood Transfusion in Elective Surgery |
| Q33371166 | Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia |
| Q37758559 | Posttraumatic massive bleeding: a challenging multidisciplinary task |
| Q34492729 | Recommendations for the transfusion management of patients in the peri-operative period. I. The pre-operative period |
| Q34988663 | Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period |
| Q35106170 | Recommendations for the transfusion management of patients in the peri-operative period. III. The post-operative period |
| Q37209117 | Recommendations for the transfusion of plasma and platelets |
| Q37119693 | Recommendations for the transfusion of red blood cells |
| Q50711378 | Red blood cell and platelet transfusions in the treatment of anemic thrombocytopenic patients. |
| Q36902425 | Red blood cell transfusion in clinical practice |
| Q50227235 | Red blood cell transfusion: 2016 clinical practice guidelines from AABB. |
| Q33421355 | Risk of bleeding and use of platelet transfusions in patients with hematologic malignancies: recurrent event analysis |
| Q37309816 | Role of nitric oxide in the prevention of severe adverse events associated with blood products |
| Q33411861 | Spontaneous subdural hematoma in the setting of immune thrombocytopenia complicated by ischemic infarcts |
| Q81458586 | Strategies to control massive abdominal bleeding |
| Q42100806 | The Effect of Hematocrit on Platelet Adhesion: Experiments and Simulations |
| Q50216213 | The Effect of Preoperative Anemia on the Outcome After Coronary Surgery |
| Q64111058 | The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition |
| Q27339343 | The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition |
| Q42284957 | The Platelet Function Analyzer (PFA-100) as a Screening Tool in Neurosurgery |
| Q43281634 | Therapeutic options for perioperatively acquired platelet dysfunctions |
| Q52565586 | Transdermal estradiol for the management of refractory uremic bleeding. |
| Q36230698 | Transfusion practice in massively bleeding patients: time for a change? |
| Q33357989 | Triggers for prophylactic use of platelet transfusions and optimal platelet dosing in thrombocytopenic dogs and cats |
| Q33357642 | Unprovoked periodontal hemorrhage, life‐threatening anemia and idiopathic thrombocytopenia purpura: an unusual case report |
| Q33403558 | Use of fresh platelet concentrate or lyophilized platelets in thrombocytopenic dogs with clinical signs of hemorrhage: a preliminary trial in 37 dogs |
| Q37778263 | What is causing the mortality in treating the anemia of chronic kidney disease: erythropoietin dose or hemoglobin level? |
| Q79345654 | [Prerequisites of a functional haemostasis. What must be considered at the scene of an accident, in the emergency room and during an operation?] |
Search more.